ATE526967T1 - Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum - Google Patents

Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum

Info

Publication number
ATE526967T1
ATE526967T1 AT04741123T AT04741123T ATE526967T1 AT E526967 T1 ATE526967 T1 AT E526967T1 AT 04741123 T AT04741123 T AT 04741123T AT 04741123 T AT04741123 T AT 04741123T AT E526967 T1 ATE526967 T1 AT E526967T1
Authority
AT
Austria
Prior art keywords
betamimetic
anticholinergic
medications containing
inhalation medications
inhalation
Prior art date
Application number
AT04741123T
Other languages
English (en)
Inventor
Christopher Meade
Michel Pairet
Michael Pieper
Ingo Konetzki
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34130044&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE526967(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE526967T1 publication Critical patent/ATE526967T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT04741123T 2003-07-31 2004-07-17 Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum ATE526967T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03017349 2003-07-31
PCT/EP2004/008013 WO2005013994A1 (en) 2003-07-31 2004-07-17 Medicaments for inhalation comprising anticholinergics and a betamimetic

Publications (1)

Publication Number Publication Date
ATE526967T1 true ATE526967T1 (de) 2011-10-15

Family

ID=34130044

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04741123T ATE526967T1 (de) 2003-07-31 2004-07-17 Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum

Country Status (5)

Country Link
EP (1) EP1651224B1 (de)
JP (1) JP2007500676A (de)
AT (1) ATE526967T1 (de)
CA (1) CA2534120C (de)
WO (1) WO2005013994A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2484382A1 (de) * 2005-03-30 2012-08-08 Schering Corporation Medikament enthaltend einem Phosphodiesterase IV Inhibitor in einer zur Inhalation geeigneten Form
EP1879579A1 (de) * 2005-05-04 2008-01-23 Boehringer Ingelheim International GmbH Inhalationsvorrichtung mit mehreren dosen eines pharmazeutischen zusammensetzung
WO2006128847A2 (en) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
CN101198313A (zh) * 2005-08-01 2008-06-11 奇斯药制品公司 通过喷雾施用的包含长效β2－激动剂的药物制剂
MX2009008794A (es) * 2007-02-19 2009-08-25 Cipla Ltd Combinaciones farmaceuticas al menos de dos broncodilatadores o de un broncodilatador con un corticosteroide.
EP2100599A1 (de) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
US9463161B2 (en) 2009-05-29 2016-10-11 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011015289A1 (en) 2009-08-04 2011-02-10 Chiesi Farmaceutici S.P.A. 8-hydroxy-5-[(1r)-1-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl]-2(1h)-quinolinone hemi-fumarate
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1258253A1 (de) * 2000-01-28 2002-11-20 Asahi Kasei Kabushiki Kaisha Neue heilmittel mit verwendung eines beta3-antagonisten
HU230804B1 (hu) * 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US6667344B2 (en) * 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
DE10203749A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203741A1 (de) * 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
JP2005523905A (ja) * 2002-03-01 2005-08-11 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ ホルモテロール（ｆｏｒｍｏｔｅｒｏｌ）超微細調合物
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
EP1452179A1 (de) * 2003-02-27 2004-09-01 CHIESI FARMACEUTICI S.p.A. Neue Kombination von hochwirksamer langzeitiger Beta-2-Agonist und einem Corticosteroid

Also Published As

Publication number Publication date
EP1651224A1 (de) 2006-05-03
WO2005013994A1 (en) 2005-02-17
EP1651224B1 (de) 2011-10-05
JP2007500676A (ja) 2007-01-18
CA2534120A1 (en) 2005-02-17
CA2534120C (en) 2012-09-11

Similar Documents

Publication Publication Date Title
UA85708C2 (ru) Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей
TW200738242A (en) Dihydropteridinones in the treatment of respiratory diseases
ATE526967T1 (de) Medikamente für inhalationen enthaltend ein anticholinergikum und ein betamimetikum
DE50213966D1 (de) pium, Ciclesonide UND einem BETAMIMETIKum ZUR BEHAMWEGSERKRANKUNGEN
IL173371A0 (en) Medicaments for inhalation comprising betamimetics and an anticholinergic
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
SE0302811D0 (sv) Novel compounds
SE0301700D0 (sv) Novel compounds
RS20090083A (en) Novel medicament compositions, based on anticholinergically effective compounds and beta -mimetics
TW200503674A (en) Therapeutic agents
SE0202539D0 (sv) Compounds
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
TW200738658A (en) Novel compounds
GB0625648D0 (en) Compounds
SE0200920D0 (sv) Novel compounds
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
SE0300480D0 (sv) Novel compounds
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
ATE538790T1 (de) Scopolamin für die behandlung von depression und ängstlichkeit
TW200640911A (en) Novel, long acting betamimetics for the treatment of respiratory diseases
SE0401762D0 (sv) Novel compounds
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
TW200740781A (en) Novel compounds
SE0302139D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties